Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
JJ Popma, P Berger, EM Ohman, RA Harrington… - Chest, 2004 - Elsevier
This chapter about antithrombotic therapy during percutaneous coronary intervention (PCI)
is part of the seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy …
is part of the seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy …
Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
RA Harrington, RC Becker, M Ezekowitz, TW Meade… - Chest, 2004 - Elsevier
This chapter about antithrombotic therapy for coronary artery disease (CAD) is part of the
Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence Based …
Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence Based …
Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary percutaneous coronary intervention: pooled patient …
Abstract Background: In the HORIZONS-AMI (Harmonizing Outcomes with
RevasculariZatiON and Stents in Acute Myocardial Infarction) trial, 3,602 patients …
RevasculariZatiON and Stents in Acute Myocardial Infarction) trial, 3,602 patients …
Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and …
S Bangalore, B Toklu, A Kotwal, A Volodarskiy… - bmj, 2014 - bmj.com
Objectives To investigate the relative benefits of unfractionated heparin, low molecular
weight heparin (LMWH), fondaparinux, and bivalirudin as treatment options for patients with …
weight heparin (LMWH), fondaparinux, and bivalirudin as treatment options for patients with …
Antithrombotic therapy after percutaneous coronary intervention from the Japanese perspective
Y Saito, Y Kobayashi, K Tanabe, Y Ikari - Cardiovascular intervention and …, 2020 - Springer
Percutaneous coronary intervention (PCI) has become a standard-of-care procedure in
patients with acute and chronic coronary syndrome. Adjunctive antithrombotic therapy …
patients with acute and chronic coronary syndrome. Adjunctive antithrombotic therapy …
[HTML][HTML] Bivalirudin versus heparin monotherapy in myocardial infarction
Background The comparative efficacy of various anticoagulation strategies has not been
clearly established in patients with acute myocardial infarction who are undergoing …
clearly established in patients with acute myocardial infarction who are undergoing …
Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical …
AM Lincoff, JA Bittl, NS Kleiman, IJ Sarembock… - The American journal of …, 2004 - Elsevier
To assess the efficacy of the direct thrombin inhibitor bivalirudin relative to heparin during
contemporary coronary intervention, 1,056 patients who underwent elective or urgent …
contemporary coronary intervention, 1,056 patients who underwent elective or urgent …
Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary …
Objectives: The purpose of this study was to compare the cost of percutaneous coronary
intervention (PCI) using bivalirudin with provisional platelet glycoprotein (GP) IIb/IIIa …
intervention (PCI) using bivalirudin with provisional platelet glycoprotein (GP) IIb/IIIa …
Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials
MA Cavender, MS Sabatine - The Lancet, 2014 - thelancet.com
Background Bivalirudin is an alternative to heparin in patients undergoing percutaneous
coronary intervention (PCI). We aimed to define the effects of a bivalirudin-based …
coronary intervention (PCI). We aimed to define the effects of a bivalirudin-based …
An updated comprehensive meta-analysis of bivalirudin vs heparin use in primary percutaneous coronary intervention
R Shah, KC Rogers, K Matin, R Askari, SV Rao - American heart journal, 2016 - Elsevier
Background Despite several randomized controlled trials and meta-analyses, the ideal
anticoagulant for patients undergoing primary percutaneous coronary intervention (PCI) …
anticoagulant for patients undergoing primary percutaneous coronary intervention (PCI) …